• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的多室药代动力学模型随机方法:线性和非线性系统中旅行路径概率和停留时间分布。

A new stochastic approach to multi-compartment pharmacokinetic models: probability of traveling route and distribution of residence time in linear and nonlinear systems.

机构信息

School of Pharmacy, Ohio State University, 500 12th West Avenue, Columbus, OH 43210, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):83-104. doi: 10.1007/s10928-010-9179-8. Epub 2010 Dec 17.

DOI:10.1007/s10928-010-9179-8
PMID:21165682
Abstract

Drug kinetics in human has been studied from both deterministic and stochastic perspectives. However, little research has been done to systematically determine the probability for a drug molecule to follow a specific traveling route. Recently a method was developed to estimate this probability and the probability density function of residence time in linear systems. In this paper, we provide a rigorous proof of the main results of the previous paper and extend the method to nonlinear multi-compartment systems. A novel concept of compartment expansion is introduced to facilitate the development of our method. This formulation resolves computational difficulties associated with nonlinear systems, allowing for direct estimation of the probability intensity coefficients, and subsequently the transition probability and probability density function of the residence time. With such expansion of the methodology, it becomes both practical and feasible to apply it in the real-world drug development where drug disposition patterns are often nonlinear. The method can be used to estimate drug exposure at any site of interest, thus may help us to gain better understanding about the impact of drug exposure on efficacy and safety.

摘要

已经从确定性和随机性两个角度研究了人体中的药物动力学。然而,很少有研究系统地确定药物分子遵循特定行进路线的概率。最近,已经开发出一种估计这种概率的方法,以及在线性系统中停留时间的概率密度函数。在本文中,我们为前一篇论文的主要结果提供了严格的证明,并将该方法扩展到非线性多室系统。引入了一种新的隔室扩展概念,以方便我们方法的发展。这种表述解决了与非线性系统相关的计算难题,允许直接估计概率强度系数,从而可以直接估计转移概率和停留时间的概率密度函数。通过这种方法的扩展,它在药物开发的实际应用中变得既实际又可行,在药物处置模式通常是非线性的情况下。该方法可用于估计任何感兴趣部位的药物暴露量,从而有助于我们更好地了解药物暴露对疗效和安全性的影响。

相似文献

1
A new stochastic approach to multi-compartment pharmacokinetic models: probability of traveling route and distribution of residence time in linear and nonlinear systems.一种新的多室药代动力学模型随机方法:线性和非线性系统中旅行路径概率和停留时间分布。
J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):83-104. doi: 10.1007/s10928-010-9179-8. Epub 2010 Dec 17.
2
New developments in using stochastic recipe for multi-compartment model: inter-compartment traveling route, residence time, and exponential convolution expansion.利用随机配方对多隔室模型的新发展:隔室间旅行路线、停留时间和指数卷积展开。
Math Biosci Eng. 2009 Jul;6(3):663-82. doi: 10.3934/mbe.2009.6.663.
3
Density functions of residence times for deterministic and stochastic compartmental systems.确定性和随机房室系统的停留时间密度函数。
Math Biosci. 2002 Nov-Dec;180:127-39. doi: 10.1016/s0025-5564(02)00110-4.
4
An approach to the residence time distribution for stochastic multi-compartment models.一种针对随机多隔室模型的停留时间分布的方法。
Math Biosci. 2004 Oct;191(2):185-205. doi: 10.1016/j.mbs.2004.06.005.
5
Stochastic interpretation of linear pharmacokinetics: a linear system analysis approach.线性药代动力学的随机解释:一种线性系统分析方法。
J Pharm Sci. 1991 Jul;80(7):621-31. doi: 10.1002/jps.2600800703.
6
Impact of saturable distribution in compartmental PK models: dynamics and practical use.房室药代动力学模型中可饱和分布的影响:动力学与实际应用
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):1-16. doi: 10.1007/s10928-016-9500-2. Epub 2017 Jan 3.
7
On the stochastic modeling of tracer kinetics.关于示踪剂动力学的随机建模
Fed Proc. 1980 Jan;39(1):104-9.
8
Use of a linearization approximation facilitating stochastic model building.使用线性化逼近方法促进随机模型的构建。
J Pharmacokinet Pharmacodyn. 2014 Apr;41(2):153-8. doi: 10.1007/s10928-014-9353-5. Epub 2014 Mar 13.
9
A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data.一种从临床前数据估算浓度依赖性药物相互作用药代动力学风险的方法。
Drug Metab Dispos. 1999 Dec;27(12):1479-87.
10
Population extinction and quasi-stationary behavior in stochastic density-dependent structured models.随机密度依赖结构模型中的种群灭绝和准平稳行为
Bull Math Biol. 2000 Mar;62(2):199-228. doi: 10.1006/bulm.1999.0147.

引用本文的文献

1
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen.开发描述新型 Fc-融合型白细胞介素-1 受体拮抗剂 HL2351 经新生儿 Fc 受体介导的再循环的药代动力学模型,以优化剂量方案。
CPT Pharmacometrics Syst Pharmacol. 2020 Oct;9(10):584-595. doi: 10.1002/psp4.12555. Epub 2020 Oct 6.
2
Clinical pharmacology considerations in biologics development.生物制品开发中的临床药理学考虑因素。
Acta Pharmacol Sin. 2012 Nov;33(11):1339-47. doi: 10.1038/aps.2012.51. Epub 2012 Sep 24.

本文引用的文献

1
New developments in using stochastic recipe for multi-compartment model: inter-compartment traveling route, residence time, and exponential convolution expansion.利用随机配方对多隔室模型的新发展:隔室间旅行路线、停留时间和指数卷积展开。
Math Biosci Eng. 2009 Jul;6(3):663-82. doi: 10.3934/mbe.2009.6.663.
2
A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs.一种基于生理学的药代动力学(PBPK)模型,用于表征和预测单克隆抗体CC49及其单链Fv构建体的处置情况。
Int Immunopharmacol. 2008 Mar;8(3):401-13. doi: 10.1016/j.intimp.2007.10.023. Epub 2007 Nov 26.
3
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.
基于生理的药代动力学(PBPK)模型,用于预测野生型和FcRn基因敲除小鼠体内IgG的组织动力学。
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):687-709. doi: 10.1007/s10928-007-9065-1. Epub 2007 Jul 18.
4
The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model.大鼠模型中淋巴系统在大分子皮下吸收中的作用。
Eur J Pharm Biopharm. 2007 Nov;67(3):759-65. doi: 10.1016/j.ejpb.2007.04.002. Epub 2007 Apr 7.
5
Using stochastic differential equations for PK/PD model development.使用随机微分方程进行药代动力学/药效学(PK/PD)模型开发。
J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):109-41. doi: 10.1007/s10928-005-2105-9.
6
Nonlinear stochastic modeling of aphid population growth.蚜虫种群增长的非线性随机建模
Math Biosci. 2005 Dec;198(2):148-68. doi: 10.1016/j.mbs.2005.07.009. Epub 2005 Sep 23.
7
An approach to the residence time distribution for stochastic multi-compartment models.一种针对随机多隔室模型的停留时间分布的方法。
Math Biosci. 2004 Oct;191(2):185-205. doi: 10.1016/j.mbs.2004.06.005.
8
Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.通过测量斯普拉格-道利大鼠和卫材高胆红素血症大鼠的门静脉和体循环血药浓度差,采用具有肝肠循环的再循环模型对雷马曲班进行药代动力学分析。
Pharm Res. 2004 Jun;21(6):1055-64. doi: 10.1023/b:pham.0000029296.07355.91.
9
Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheep.描述皮下注射重组人瘦素后绵羊淋巴吸收情况的药代动力学模型。
Pharm Res. 2003 Aug;20(8):1156-62. doi: 10.1023/a:1025036611949.
10
A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.一种通过测量门静脉和体循环血液浓度差异来建立肝肠循环的再循环模型。
J Pharmacokinet Pharmacodyn. 2003 Apr;30(2):119-44. doi: 10.1023/a:1024415730100.